Ofatumumab for treating relapsing multiple sclerosis

  • Technology appraisal guidance
  • TA699
  • Published: 

History

Documents created during the development process.

Declaration of interests

Final draft guidance

Invitation to participate

Notes

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators